Use of Tricyclic Antidepressants in Recipients of Heart Transplants
| Autor: | David Bienenfeld, Marcia Slomowitz, Jerald Kay, Grace Nadolny, Lawrence Zimmer, N. Travis Marvel, Peter Geier, Judy Burk |
|---|---|
| Rok vydání: | 1991 |
| Předmět: |
Adult
medicine.medical_specialty Amitriptyline Nortriptyline Antidepressive Agents Tricyclic Postoperative Complications Arts and Humanities (miscellaneous) Internal medicine Adaptation Psychological Heart rate Humans Medicine Adverse effect Applied Psychology Depression (differential diagnoses) chemistry.chemical_classification Depressive Disorder medicine.diagnostic_test business.industry Desipramine Middle Aged Transplantation Psychiatry and Mental health Blood pressure chemistry Anesthesia Heart Transplantation Antidepressant business Electrocardiography Tricyclic |
| Zdroj: | Psychosomatics. 32:165-170 |
| ISSN: | 0033-3182 |
| DOI: | 10.1016/s0033-3182(91)72087-2 |
| Popis: | Cardiac transplantation has become an accepted treatment for certain endstage cardiac disease patients. Depression and significant psychosocial stress among heart transplant recipients are not uncommon, but published reports about the use of antidepressants in these persons are very rare. The authors of this study report on a group of nine heart transplant recipients treated with antidepressant medicines. Seven patients achieved clinical remissions of their depression, and only two were unable to tolerate the noncardiac side effects of the medication. Indicators of autonomic, electrocardiographic, and hemodynamic functions showed no adverse effects. Although the study is based on a small sample, it appears that tricyclic antidepressants are safe and effective in heart transplant recipients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|